DermTech Inc at Cowen Health Care Conference Transcript
All right. It's up. Day three, TD Cowen annual healthcare conference. I'm Max Masucci, life science and diagnostic tools analyst. Today, we're joined by Kevin Sun, CFO of DermTech.
Questions & Answers
And I think a question that we've been asking -- before we jump into the details -- are just some 2022 key highlights, key takeaways, learnings, and how you've translated that into your 2023 strategy.
Yeah. Thanks for having DermTech. It's a pleasure to be here.
I think key learnings that we had from 2022 is -- it was a good year for us. We had over 50% growth in our volumes, and that's a healthy level. We ended the year at over 68,000 samples. So that's a very healthy level.
Where we had some pressure, though, was on the ASP side, and that was from -- pressure from the commercial payers, mostly non-contracted. Payment patterns and payment rates were just decreased over that time period, and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |